Cargando…

Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children

BACKGROUND: Over 250 million children under 5 years, globally, are at risk of developmental delay. Interventions during the first 2 years of life have enduring positive effects if children at risk are identified, using standardized assessments, within this window. However, identifying developmental...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Michelle, Bassani, Diego, Albernaz, Elaine, Bertoldi, Andrea D., Silveira, Mariangela F., Matijsevich, Alicia, Anselmi, Luciana, Cruz, Suélen, Halal, Camila S., Tovo-Rodrigues, Luciana, Cruz, Gloria Isabel Nino, Metgud, Deepa, Santos, Ina S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783969/
https://www.ncbi.nlm.nih.gov/pubmed/36564728
http://dx.doi.org/10.1186/s12887-022-03794-1
_version_ 1784857700086054912
author Fernandes, Michelle
Bassani, Diego
Albernaz, Elaine
Bertoldi, Andrea D.
Silveira, Mariangela F.
Matijsevich, Alicia
Anselmi, Luciana
Cruz, Suélen
Halal, Camila S.
Tovo-Rodrigues, Luciana
Cruz, Gloria Isabel Nino
Metgud, Deepa
Santos, Ina S.
author_facet Fernandes, Michelle
Bassani, Diego
Albernaz, Elaine
Bertoldi, Andrea D.
Silveira, Mariangela F.
Matijsevich, Alicia
Anselmi, Luciana
Cruz, Suélen
Halal, Camila S.
Tovo-Rodrigues, Luciana
Cruz, Gloria Isabel Nino
Metgud, Deepa
Santos, Ina S.
author_sort Fernandes, Michelle
collection PubMed
description BACKGROUND: Over 250 million children under 5 years, globally, are at risk of developmental delay. Interventions during the first 2 years of life have enduring positive effects if children at risk are identified, using standardized assessments, within this window. However, identifying developmental delay during infancy is challenging and there are limited infant development assessments suitable for use in low- and middle-income (LMIC) settings. Here, we describe a new tool, the Oxford Neurodevelopment Assessment (OX-NDA), measuring cognition, language, motor, and behaviour, outcomes in 1-year-old children. We present the results of its evaluation against the Bayley Scales of Infant Development IIIrd edition (BSID-III) and its psychometric properties. METHODS: Sixteen international tools measuring infant development were analysed to inform the OX-NDA’s construction. Its agreement with the BSID-III, for cognitive, motor and language domains, was evaluated using intra-class correlations (ICCs, for absolute agreement), Bland-Altman analyses (for bias and limits of agreement), and sensitivity and specificity analyses (for accuracy) in 104 Brazilian children, aged 12 months (SD 8.4 days), recruited from the 2015 Pelotas Birth Cohort Study. Behaviour was not evaluated, as the BSID-III’s adaptive behaviour scale was not included in the cohort’s protocol. Cohen’s kappas and Cronbach’s alphas were calculated to determine the OX-NDA’s reliability and internal consistency respectively. RESULTS: Agreement was moderate for cognition and motor outcomes (ICCs 0.63 and 0.68, p < 0.001) and low for language outcomes (ICC 0.30, p < 0.04). Bland-Altman analysis showed little to no bias between measures across domains. The OX-NDA’s sensitivity and specificity for predicting moderate-to-severe delay on the BSID-III was 76, 73 and 43% and 75, 80 and 33% for cognition, motor and language outcomes, respectively. Inter-rater (k = 0.80-0.96) and test-rest (k = 0.85-0.94) reliability was high for all domains. Administration time was < 20 minutes. CONCLUSION: The OX-NDA shows moderate agreement with the BSID-III for identifying infants at risk of cognitive and motor delay; agreement was low for language delay. It is a rapid, low-cost assessment constructed specifically for use in LMIC populations. Further work is needed to evaluate its use (i) across domains in populations beyond Brazil and (ii) to identify language delays in Brazilian children. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-022-03794-1.
format Online
Article
Text
id pubmed-9783969
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97839692022-12-24 Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children Fernandes, Michelle Bassani, Diego Albernaz, Elaine Bertoldi, Andrea D. Silveira, Mariangela F. Matijsevich, Alicia Anselmi, Luciana Cruz, Suélen Halal, Camila S. Tovo-Rodrigues, Luciana Cruz, Gloria Isabel Nino Metgud, Deepa Santos, Ina S. BMC Pediatr Research BACKGROUND: Over 250 million children under 5 years, globally, are at risk of developmental delay. Interventions during the first 2 years of life have enduring positive effects if children at risk are identified, using standardized assessments, within this window. However, identifying developmental delay during infancy is challenging and there are limited infant development assessments suitable for use in low- and middle-income (LMIC) settings. Here, we describe a new tool, the Oxford Neurodevelopment Assessment (OX-NDA), measuring cognition, language, motor, and behaviour, outcomes in 1-year-old children. We present the results of its evaluation against the Bayley Scales of Infant Development IIIrd edition (BSID-III) and its psychometric properties. METHODS: Sixteen international tools measuring infant development were analysed to inform the OX-NDA’s construction. Its agreement with the BSID-III, for cognitive, motor and language domains, was evaluated using intra-class correlations (ICCs, for absolute agreement), Bland-Altman analyses (for bias and limits of agreement), and sensitivity and specificity analyses (for accuracy) in 104 Brazilian children, aged 12 months (SD 8.4 days), recruited from the 2015 Pelotas Birth Cohort Study. Behaviour was not evaluated, as the BSID-III’s adaptive behaviour scale was not included in the cohort’s protocol. Cohen’s kappas and Cronbach’s alphas were calculated to determine the OX-NDA’s reliability and internal consistency respectively. RESULTS: Agreement was moderate for cognition and motor outcomes (ICCs 0.63 and 0.68, p < 0.001) and low for language outcomes (ICC 0.30, p < 0.04). Bland-Altman analysis showed little to no bias between measures across domains. The OX-NDA’s sensitivity and specificity for predicting moderate-to-severe delay on the BSID-III was 76, 73 and 43% and 75, 80 and 33% for cognition, motor and language outcomes, respectively. Inter-rater (k = 0.80-0.96) and test-rest (k = 0.85-0.94) reliability was high for all domains. Administration time was < 20 minutes. CONCLUSION: The OX-NDA shows moderate agreement with the BSID-III for identifying infants at risk of cognitive and motor delay; agreement was low for language delay. It is a rapid, low-cost assessment constructed specifically for use in LMIC populations. Further work is needed to evaluate its use (i) across domains in populations beyond Brazil and (ii) to identify language delays in Brazilian children. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-022-03794-1. BioMed Central 2022-12-23 /pmc/articles/PMC9783969/ /pubmed/36564728 http://dx.doi.org/10.1186/s12887-022-03794-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Fernandes, Michelle
Bassani, Diego
Albernaz, Elaine
Bertoldi, Andrea D.
Silveira, Mariangela F.
Matijsevich, Alicia
Anselmi, Luciana
Cruz, Suélen
Halal, Camila S.
Tovo-Rodrigues, Luciana
Cruz, Gloria Isabel Nino
Metgud, Deepa
Santos, Ina S.
Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children
title Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children
title_full Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children
title_fullStr Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children
title_full_unstemmed Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children
title_short Construction and validation of the Oxford Neurodevelopment Assessment (OX-NDA) in 1-year-old Brazilian children
title_sort construction and validation of the oxford neurodevelopment assessment (ox-nda) in 1-year-old brazilian children
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783969/
https://www.ncbi.nlm.nih.gov/pubmed/36564728
http://dx.doi.org/10.1186/s12887-022-03794-1
work_keys_str_mv AT fernandesmichelle constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren
AT bassanidiego constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren
AT albernazelaine constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren
AT bertoldiandread constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren
AT silveiramariangelaf constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren
AT matijsevichalicia constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren
AT anselmiluciana constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren
AT cruzsuelen constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren
AT halalcamilas constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren
AT tovorodriguesluciana constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren
AT cruzgloriaisabelnino constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren
AT metguddeepa constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren
AT santosinas constructionandvalidationoftheoxfordneurodevelopmentassessmentoxndain1yearoldbrazilianchildren